Unknown OBSERVATIONAL NCT00792974

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

End-of-Life Fear in Patients With End-Stage Lung Disease: Fears of Death and Dying, Wishes and Needs of Patients With Severe COPD

Sponsor: AstraZeneca

Conditions Chronic Obstructive Pulmonary Disease Depression End-of-Life Fear Fear About Death and Dying

Interventions A brief psycho-educational intervention

Updated 7 times since 2017 Last updated: Feb 4, 2009 Started: Oct 31, 2008 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00792974, this observational or N/A phase trial focuses on Chronic Obstructive Pulmonary Disease and Depression and remains ongoing. Sponsored by AstraZeneca, it has been updated 7 times since 2008, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Dec 2024 — Present [monthly]

Unknown
Sep 2024 — Dec 2024 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Philipps University Marburg

Data source: Philipps University Marburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marburg, Germany
• Schönau am Königssee, Germany